Wingstop reported strong Q4 results, buoyed by EPS gains but missed revenue expectations slightly.

The fourth quarter of 2024 was marked by a 6.8% decline in gross merchandise sales (GMS), totaling $3.7 billion, primarily ...

Despite recent underperformance, I remain long-term bullish on Baidu due to its undervaluation and growth potential in AI. Read my BIDU thesis.

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

In this article, we will take a look into Johnson & Johnson's (NYSE:JNJ) DCF analysis, a reliable and data-driven approach to ...

The market expects Fate Therapeutics (FATE) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Sales growth of 7%, GAAP EPS of $3.19 and Adjusted EPS of $4.26On track to close De La Rue Authentication acquisition in the ...